Insider Trades18 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Sell | PEPG | Kasra Kasraian | Chief Technical Officer | 1,233 | $1.41 | $206.4M | -61.79% | +127.48% | $1.7K | -2.40% | 10b5-1 | — |
| Mar 4, 2026 | Sell | PEPG | Paul Streck | EVP, Head of R&D | 1,879 | $6.23 | $206.4M | -61.79% | +127.48% | $11.7K | -1.22% | 10b5-1 | — |
| Mar 4, 2026 | Sell | PEPG | Noel Donnelly | Chief Financial Officer | 2,084 | $6.23 | $206.4M | -61.79% | +127.48% | $13.0K | -0.92% | 10b5-1 | — |
| Mar 4, 2026 | Sell | PEPG | James G Mcarthur | President and CEO | 5,275 | $6.23 | $206.4M | -61.79% | +127.48% | $32.9K | -0.88% | 10b5-1 | — |
| May 30, 2025 | Buy | PEPG | Paul Streck | EVP, Head of R&D | 8,375 | $1.24 | $206.4M | -61.79% | +127.48% | $10.4K | +43.10% | — | — |
| Apr 17, 2025 | Buy | PEPG | James G Mcarthur | President and CEO | 10,000 | $1.35 | $206.4M | -61.79% | +127.48% | $13.6K | +9.62% | — | — |
| Apr 8, 2025 | Buy | PEPG | James G Mcarthur | President and CEO | 41,500 | $1.15 | $206.4M | -61.79% | +127.48% | $47.7K | +66.49% | — | — |
| Feb 26, 2025 | Sell | PEPG | Mary Beth Delena | General Counsel | 1,432 | $1.68 | $206.4M | -61.79% | +127.48% | $2.4K | -47.73% | 10b5-1 | — |
| Feb 26, 2025 | Sell | PEPG | Noel Donnelly | Chief Financial Officer | 1,527 | $1.68 | $206.4M | -61.79% | +127.48% | $2.6K | -47.72% | 10b5-1 | — |
| Jul 24, 2024 | Sell | PEPG | Michelle L Mellion | Chief Medical Officer | 15,544 | $14.13 | $206.4M | -61.79% | +127.48% | $219.7K | +0.00% | 10b5-1 | — |
| Jul 18, 2024 | Sell | PEPG | Michelle L Mellion | Chief Medical Officer | 25,250 | $14.21 | $206.4M | -61.79% | +127.48% | $358.7K | +0.00% | 10b5-1 | — |
| Jul 12, 2024 | Sell | PEPG | Michelle L Mellion | Chief Medical Officer | 18,378 | $14.11 | $206.4M | -61.79% | +127.48% | $259.4K | +0.00% | 10b5-1 | — |
| Jul 1, 2024 | Sell | PEPG | Michelle L Mellion | Chief Medical Officer | 1,824 | $14.11 | $206.4M | -61.79% | +127.48% | $25.7K | +0.00% | 10b5-1 | — |
| Jun 24, 2024 | Sell | PEPG | Michelle L Mellion | Chief Medical Officer | 18,520 | $14.20 | $206.4M | -61.79% | +127.48% | $263.0K | +0.00% | 10b5-1 | — |
| Jun 11, 2024 | Sell | PEPG | Michelle L Mellion | Chief Medical Officer | 3,172 | $14.13 | $206.4M | -61.79% | +127.48% | $44.8K | +0.00% | 10b5-1 | — |
| Jun 5, 2024 | Sell | PEPG | Michelle L Mellion | SVP, Clinical Development | 17,312 | $14.14 | $206.4M | -61.79% | +127.48% | $244.8K | +0.00% | 10b5-1 | — |
| May 17, 2024 | Sell | PEPG | Niels Svenstrup | SVP, Chem. Mfg & Controls | 10,000 | $13.41 | $206.4M | -61.79% | +127.48% | $134.1K | -100.00% | 10b5-1 | — |
| Nov 30, 2023 | Buy | PEPG | James G Mcarthur | President and CEO | 1,694 | $4.17 | $206.4M | -61.79% | +127.48% | $7.1K | — | — | — |